Literature DB >> 33196154

N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.

Frances A Wood1, James P Howard1, Judith A Finegold1, Alexandra N Nowbar1, David M Thompson1, Ahran D Arnold1, Christopher A Rajkumar1, Susan Connolly1, Jaimini Cegla2, Chris Stride3, Peter Sever4, Christine Norton5, Simon A M Thom4, Matthew J Shun-Shin4, Darrel P Francis4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33196154     DOI： 10.1056/NEJMc2031173

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  49 in total

1.  The neuropsychology of statin intolerance.

Authors:  Jennifer G Robinson
Journal:  Nat Rev Cardiol       Date:  2021-01-06       Impact factor: 32.419

2.  The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs.

Authors:  Emily Herrett; Elizabeth Williamson; Kieran Brack; Alexander Perkins; Andrew Thayne; Haleema Shakur-Still; Ian Roberts; Danielle Prowse; Danielle Beaumont; Zahra Jamal; Ben Goldacre; Tjeerd van Staa; Thomas M MacDonald; Jane Armitage; Michael Moore; Maurice Hoffman; Liam Smeeth
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

Review 3.  [Diagnostics and treatment of statin-associated muscle symptoms].

Authors:  Ursula Kassner; Stefanie Grunwald; Dominik Spira; Nikolaus Buchmann; Thomas Bobbert; Elisabetta Gazzerro; Tim Hollstein; Simone Spuler; Elisabeth Steinhagen-Thiessen
Journal:  Internist (Berl)       Date:  2021-06-18       Impact factor: 0.743

Review 4.  Aspirin, Statins, and Primary Prevention: Opportunities for Shared Decision Making in the Face of Uncertainty.

Authors:  Amit Jhaveri; Rachel A Sibley; Erica S Spatz; John Dodson
Journal:  Curr Cardiol Rep       Date:  2021-05-07       Impact factor: 2.931

Review 5.  [Modern lipid-lowering drugs-A means to counter the problem of undertreatment?]

Authors:  Julius L Katzmann; Ulrich Laufs
Journal:  Internist (Berl)       Date:  2022-04-07       Impact factor: 0.743

6.  Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults.

Authors:  Ciaran N Kohli-Lynch; Brandon K Bellows; Yiyi Zhang; Bonnie Spring; Dhruv S Kazi; Mark J Pletcher; Eric Vittinghoff; Norrina B Allen; Andrew E Moran
Journal:  J Am Coll Cardiol       Date:  2021-11-16       Impact factor: 24.094

7.  Association Between Vitamin D Supplementation and Statin-Associated Muscle Symptoms: A Systematic Review.

Authors:  Chong Boon Teo; Pek Yan Tan; Ryan Yong Kiat Tay; Joan Khoo; Gerald F Watts; Wann Jia Loh
Journal:  High Blood Press Cardiovasc Prev       Date:  2022-06-29

8.  Old Drugs for an Old Pathology? Drug Repurposing for Calcific Aortic Valve Disease.

Authors:  Francesca Bartoli-Leonard; Elena Aikawa
Journal:  Circ Res       Date:  2021-04-29       Impact factor: 17.367

Review 9.  Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom.

Authors:  Timothy Mark Reynolds; Alison Pottle; Sadat H Quoraishi
Journal:  Vasc Health Risk Manag       Date:  2021-05-21

10.  Tolerability of statin-based management of patients with a history of statin-associated muscle symptoms: protocol for a systematic review.

Authors:  Fanny Villoz; Christina Lyko; Cinzia Del Giovane; Nicolas Rodondi; Manuel R Blum
Journal:  BMJ Open       Date:  2021-08-03       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.